SCHEMBL4012501

SCHEMBL4012501

CC(C)COC(=O)N1CC=C(B2OC(C)(C)C(C)(C)O2)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.38
MAPK1 P28482 1/20 0.36
MEN1 O00255 1/20 0.34
HPGD P15428 1/20 0.34
KMT2A Q03164 1/20 0.34
KIT P10721 1/20 0.34
HRH1 P35367 2/20 0.33
NR1H2 P55055 1/20 0.33
NR1H3 Q13133 1/20 0.33
SLC6A15 Q9H2J7 1/20 0.33
PPARG P37231 1/20 0.33
PPARA Q07869 1/20 0.33
WDR5 P61964 1/20 0.32
RAB9A P51151 1/20 0.32
P2RX4 Q99571 1/20 0.32
PTGDR2 Q9Y5Y4 2/20 0.32
JAK2 O60674 2/20 0.32
JAK1 P23458 2/20 0.32
GPR119 Q8TDV5 1/20 0.32
HRH2 P25021 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26913951 0.84 P2RX7 (0.40) P2RX7MAPK1KITSLC6A15P2RX4
SCHEMBL14142233 0.82 P2RX7 (0.37) P2RX7MAPK1SLC6A15
SCHEMBL2359115 0.82 SMN1; SMN2 (0.44) P2RX7MAPK1MEN1HPGDKMT2A
SCHEMBL22657130 0.82 P2RX7 (0.43) P2RX7MAPK1MEN1KMT2AKIT
SCHEMBL1103983 0.81 GRM5 (0.48) MEN1HPGDKMT2AHRH1NR1H2
SCHEMBL26204499 0.80 P2RX7 (0.43) P2RX7MAPK1
SCHEMBL39349 0.79 PDK4 (0.43) P2RX7MAPK1NR1H2
SCHEMBL28994220 0.79 P2RX7 (0.42) P2RX7MAPK1
SCHEMBL28994218 0.79 P2RX7 (0.42) P2RX7MAPK1
SCHEMBL22539474 0.78 P2RX7 (0.39) P2RX7MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080682-A1 PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS GLAXO GROUP LIMITED (GB) 2009-07-02 WO disclosed
EP-1745038-A1 FUSED HETEROARYL DERIVATIVES FOR USE AS P38 KINASE INHIBITORS IN THE TREATMENT OF I.A. RHEUMATOID ARTHRITIS SMITHKLINE BEECHAM CORPORATION (US) 2007-01-24 EP disclosed
WO-2005073219-A1 FUSED HETEROARYL DERIVATIVES FOR USE AS P38 KINASE INHIBITORS IN THE TREATMENT OF I.A. RHEUMATOID ARTHRITIS SMITHKLINE BEECHAM CORPORATION (US) 2005-08-11 WO disclosed